Therapeutic Cloning: Pros, Cons, and Ethical Debate
This paper examines therapeutic cloning — also known as Somatic Cell Nuclear Transfer — from scientific, ethical, and policy perspectives. It begins by defining the procedure and explaining its current developmental limitations, then surveys the broad spectrum of arguments for and against its use. Proponents highlight the potential to develop perfectly matched replacement organs and disease-specific stem cell lines for conditions such as Alzheimer's, Parkinson's, and diabetes. Opponents raise concerns about the moral status of the human embryo, the risks to women donors, commercialization, and the prospect of a slippery slope toward reproductive cloning. The paper also considers international policy responses, including the U.K.'s regulatory framework and the U.S. President's Council on Bioethics, concluding with a summary of the Council's recommendation for a moratorium on therapeutic cloning pending further ethical and scientific review.
- Introduction to Therapeutic Cloning: Defines therapeutic cloning and frames the debate
- The Science and Current Limitations: Explains SCNT procedure and research gaps
- Arguments in Favor of Therapeutic Cloning: Medical promise, disease research, and scientific consensus
- Ethical and Moral Objections: Embryo moral status, Church doctrine, slippery slope
- Legal, Social, and Commercialization Concerns: Human rights, eugenics risks, and commercialization
- Policy Responses and Bioethics Oversight: UK framework and US bioethics council recommendations
- Conclusion: Human dignity and the case for a moratorium
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Presents a genuinely balanced survey of competing positions — scientific, religious, legal, and political — without collapsing into advocacy, which makes it a reliable reference for understanding the debate.
- Grounds abstract ethical claims in concrete examples (insulin-secreting cells for diabetes, nerve cells for Parkinson's, Alzheimer's stem cell lines), helping readers connect philosophy to practice.
- Uses direct quotation strategically — from Pope John Paul II, the National Academy of Sciences, Dr. Kass, and legislative bodies — to let primary voices anchor each side of the argument.
Key academic technique demonstrated
The paper demonstrates structured dialectical argumentation: it defines its subject precisely, establishes scientific context and limitations, then systematically pairs each pro-cloning argument with a corresponding counter-argument before moving to policy implications. This back-and-forth architecture keeps the analysis fair and prevents the essay from reading as a position paper, while still building toward a clear policy conclusion.
Structure breakdown
The paper opens with a definition of therapeutic cloning and an honest account of how far the science has — and has not — progressed. It then presents the case for the procedure (medical promise, disease research, international consensus) before pivoting to objections (embryo moral status, Church doctrine, slippery-slope fears, risks to women, commercialization). A penultimate section addresses policy responses in the U.K. and the U.S., and the paper closes with the President's Council recommendation for a four-year moratorium, framed by a summary quotation on human dignity.
Introduction to Therapeutic Cloning
Recent years have seen intense debate on the ethicality of human cloning and therapeutic cloning. While the former involves the reproduction of a new human — a clone of the adult from whom the DNA was taken — therapeutic cloning has a very different goal. Nevertheless, therapeutic cloning, too, has come under significant scrutiny. This paper focuses on therapeutic cloning alone and explores the possible pros and cons of the procedure. First, however, it is important to define therapeutic cloning so that the discussion that follows is viewed within the correct contextual framework.
Therapeutic cloning, also known as Somatic Cell Nuclear Transfer (SCNT), is a procedure that involves removing the DNA from a human cell, inserting it into the DNA extracted from a woman's ovum, and then giving the resultant ovum an electrical shock to begin the formation of an embryo. The procedure results in a pre-embryo being formed in a small percentage of cases (Robinson).
The Science and Current Limitations
The pre-embryo that is formed is then allowed to develop and produce stem cells, after which the stem cells are removed, leading to the death of the pre-embryo. The stem cells are subsequently encouraged to grow into either tissue or an organ needed to treat a patient. Theoretically, such stem cells can be used to develop replacement organs. It is envisaged that therapeutic cloning, if successful, will lead to perfectly matched organs that could save countless lives while improving the quality of life for innumerable people who are physically or physiologically challenged (Robinson).
An equally important context is the fact that scientists have yet to achieve several critical stages in embryonic stem cell research. The first is the ability to consistently isolate embryonic stem cells and grow them into the desired type of tissue. The second stage will be to determine the correct mode of delivery of the specialized cells to the part of the body that is diseased or injured. The third stage will involve tissue engineering. Only once research has successfully addressed all of these steps can scientists begin to determine whether there are any long-term benefits, and whether the cells multiply as theorized and interact with and replace injured cells (Shannon).
Given the current status of therapeutic cloning described above, it must be noted that the controversy and debate over the desirability of the procedure center on ethical questions — particularly those concerning the moral status of the cloned human embryo and the implied consequences of routinizing and legalizing the production and destruction of such embryos (Berkowitz).
Create your account
Always verify citation format against your institution’s current style guide requirements.